Will Trump's move raise prices of drugs around the world? Read more at straitstimes.com. Read more at straitstimes.com.

The Trump administration has identified growth in the nuclear energy industry as a critical component of the President’s ...

The Executive Orders’ directives to facilitate the construction of advanced reactors and privately funded nuclear fuel ...

Shares rise, CBA tops $300b; suitor looks to terminate Mayne Pharma buyout; uranium stocks rally; President Xi ‘very tough’ ...

The U.S. is proposing major policy changes to its healthcare sector, including imposing tariffs on global manufacturers. Click to read.

In a letter to the Department of Commerce, Novo Nordisk argued that unsanctioned compounded semaglutide, mostly from China, ...

Pharma company stocks tumbled after Donald Trump announced a plan to reduce U.S. drug prices, but regained some ground on belief the plan would be hard to implement Drug prices are expected to decline ...

While the Trump administration’s threat of pharmaceutical import tariffs and most favored nation (MFN) drug pricing has ...

A February executive order on pharmaceutical price transparency does nothing to change the incentives that keep costs opaque.

The president has signed an executive order stating that the US will institute a “most-favored-nation” policy, whereby the US will pay the same price for a drug as the nation that pays the lowest ...

President Trump has elevated an issue Democrats have been jawboning about for years. The president issued an executive order ...